Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention. (2021)
Attributed to:
Cambridge Confidence in Concepts: translating pathophysiological insights for patient benefit
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1073/pnas.2023025118
PubMed Identifier: 33619107
Publication URI: http://europepmc.org/abstract/MED/33619107
Type: Journal Article/Review
Volume: 118
Parent Publication: Proceedings of the National Academy of Sciences of the United States of America
Issue: 9
ISSN: 0027-8424